CD79A Gene Mutation
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Ibrutinib Combined With Rituximab for Treatment of Relapsed Refractory MYD88 and CD79A/B (or CD79B Alone) DLBCL Who Have Received at Least Two Prior Therapies (NCT04994626) | Chinese Academy of Medical Sciences | 2021-10-01 |
| Zanubrutinib Combined With Standard Chemotherapy in the Treatment for Patients With Diffuse Large B Cell Lymphoma (NCT04668365) | Henan Cancer Hospital | 2020-12-25 |
Track CD79A Gene Mutation automatically
Every clearance here is in the API, with alerts when new ones post.